Directors and Senior Advisors
Director, New Frontier Health
Dr. Leong is a medical doctor in private practice specializing in Urology. After graduating from the University of Hong Kong in 1962, Dr. Leong worked in the Department of Surgery in Hong Kong University for 16 years. In addition to training medical students, Dr. Leong also conducted cutting-edge research in his specialist fields of urology. His major research contributions include experiments and the human use of the stomach for bladder replacement and urinary diversion. Dr. Leong was appointed Hunterian Professor by the Royal College of Surgeons of England in 1975. He was the first Hong Kong-born Chinese doctor to have received this accolade.
Dr. Leong’s qualifications to serve on our board of directors include his extensive network and deep knowledge in the healthcare and education industries and his significant management experience in both the public and private sectors.
Director, New Frontier Health
Professor Ma has extensive experience in the banking and financial sectors. He started his career at Chase Manhattan Bank in 1973 and returned to Chase Manhattan as Asia-Pacific Managing Director and Area Director of Global Private Bank in 1998. Following the merger of Chase Manhattan and JP Morgan in 2001, Professor Ma was appointed by JP Morgan Private Bank as Asia-Pacific Chief Executive. In 2001, he joined Pacific Century Cyberworks (PCCW) Limited as an Executive Director and was appointed Chief Financial Officer in 2002.
Professor Ma was previously the Secretary for Financial Services and the Treasury of the Hong Kong Special Administrative Region (HKSAR) Government from 2002 to 2007. Professor Ma held the position of the Secretary for Commerce and Economic Development of the HKSAR Government from 2007 to 2008. He is currently a non-official member of the HKSAR Government Chief Executive’s Council of Advisers on Innovation and Strategic Development, a member of the International Advisory Council of China Investment Corporation and the Global Advisory Council of Bank of America. Professor Ma was awarded the Gold Bauhinia Star medal in 2009 and was appointed a Justice of the Peace in 2010.
Besides his corporate and government positions, Professor Ma has also taken various roles in multiple universities in Asia. In 2008, Professor Ma took up an honorary professorship at the School of Economics and Finance at the University of Hong Kong. In August 2013, he was also appointed an Honorary Professor of Business Administration at the Chinese University of Hong Kong. He is currently the Council Chairman of The Education University of Hong Kong.
Professor Ma’s qualifications to serve our board of directors include his over 40 years of public and private sector experience, his deep and extensive financial sector experience his experience as a board member and executive officer of some of the biggest Asian public companies in a variety of industries.
Director, New Frontier Health
Mr. Fu received a Bachelor’s and Master’s Degree in History from Peking University in Beijing, China.
Director, New Frontier Group
Mr. Meng Gao is also Managing Director of the Group CEO’s Office at Nan Fung Group, a major founding investor of New Frontier. Meng is a representative of Nan Fung on the Board of New Frontier.
Prior to joining Nan Fung, Meng was a Managing Director at Blackstone’s Private Equity Group in Hong Kong. At Blackstone, he was involved in a number of transactions across multiple industries. Before joining Blackstone, Meng was a Senior Vice President at Oaktree Capital Management, where he was involved in sourcing, structuring and executing private equity investments in China. Prior to that, Mr. Gao was an investment banker with Credit Suisse and JPMorgan in New York.
Meng received a Bachelor of Economics degree from Peking University, an M.A. from Yale University and an M.B.A. from the Wharton School of the University of Pennsylvania, where he graduated with Honours.
Director, New Frontier Group
Carlos is also the Founding Partner of City Square REI, a regional real estate private equity fund, where he had executed some of the most important Real Estate transactions including Garden Square, a major Grade A skyscraper in the centre of Shanghai. He is the Chief Investment Officer and was instrumental in establishment City Square REI’s Business in Greater China. Carlos is based in Hong Kong and Shanghai. Prior to founding City Square REI, he was also a senior member of DTZ China Investment and Tesco China.
Carlos is also the Founder of Kland Capital, which has invested in different business sectors such as Property Consultant, F&B retail and Healthcare business.
Carlos also serves on the Boards of TingHo Development Group (Ting Hsin’s Real Estate investment vehicle).
Carlos is a member of Royal Institution of Chartered Surveyors (RICS) and He holds a Master’s Degree from King’s College London University.
Director, New Frontier Group
Hong-chen is currently the Executive Director of Master Kong, one of the largest food and beverage companies in Asia. Mr. Wei is also a key leader of TingHsin Group, one of Asia’s largest consumer conglomerate with interests across multiple industries, including Master Kong, FamilyMart China (leading convenience store chain in China), Dicos (the 3rd largest fast food chain in China), Taipei 101 (one of the tallest buildings in the world), Taiwan Star (leading mobile operator in Taiwan), and others.
Before joining Master Kong, Mr. Wei worked at Blackstone’s New York office, PepsiCo Chairperson and CEO office directly under the leadership of Indra Nooyi (PepsiCo Chairperson and CEO) and Asahi Group in Tokyo.
Mr. Wei received his Bachelor degree from Imperial College London, Master’s degree from Waseda University, and MBA from Harvard Business School.
Professor David D. Ho, M.D. is the founding Scientific Director and Chief Executive Officer of the Aaron Diamond AIDS Research Center, as well as the Irene Diamond Professor at The Rockefeller University. He has been at the forefront of AIDS research since the beginning of the epidemic. His elegant studies in the mid 1990’s unveiled the dynamic nature of HIV replication in vivo and revolutionized our basic understanding of this horrific disease. This knowledge led Dr. Ho to champion combination antiretroviral therapy that resulted in unprecedented control of HIV in patients since 1996. AIDS mortality in richer nations has declined dramatically, and a massive international effort is now underway to bring such life-saving treatment to millions in the developing world. To date over 10 million patients have benefitted from combination antiretroviral therapy. Dr. Ho has been a major driving force behind this major medical breakthrough in what is arguably the worst plague in human history. For his accomplishments, Dr. Ho has been recognized in multiple ways, including fourteen honorary doctorates and election to the National Academy of Medicine (formerly the Institute of Medicine, National Academy of Sciences). He was named Time Magazine’s Man of the Year in 1996, and was the recipient of a Presidential Medal from Bill Clinton in 2001.
BBS, JP, PhD, RSW
Dr. Joseph Kwok, Registered Social Worker (RSW), Ph.D., Bronze Bauhinia Star, Justice of Peace, was a former Associate Professor of the City University of Hong Kong. Dr. Kwok has intensive and extensive involvement in disability movements at global, regional and local levels.
He is a member of RI Global Executive Committee, and Vice Chair of its Social Commission;the Vice Chair of the Asian Pacific Disability Forum. He had participated in international and regional activities related to the drafting, adoption and monitoring of the UN Asia and Pacific Decade of Disabled Persons 1993-2012, A/P New Decade 2013-2022, and the UN Convention on the Rights of Persons with Disabilities.
In Hong Kong, he had served in the following positions in HKSAR Government Committees: Chairman of the Rehabilitation Advisory Committee, a member of the Women’s Commission, and a member of the Community Investment and Inclusion Fund. Dr. Kwok had served in following public bodies: Equal Opportunity Commission, Public Complaints Committee of Hospital Authority, the Governing Board of Kowloon Hospital and Eye Hospital, Admissions, Budgets and Allocation Committees of Community Chest. He is currently a Vice Chair of Hong Kong Joint Council for People with Disabilities, a Members of Voting Committee of Riding For the Disabled Association, Chairman of Fu Hong Society, and a member of Research Ethics Committee of Hospital Authority Kowloon Central and Kowloon East Clusters.
In 2006, Dr. Kwok received the Kazuo Itoga Memorial Award by the Shiga Prefecture Government of Japan in recognition of his contribution to disability work in both Hong Kong and the Region.
M.Soc.Sc. (HKU), RSW, JP.
Mrs. Victoria Kwok, Registered Social Worker (RSW) and Justice of Peace, was former Social Services Director of The Salvation Army Hong Kong and Macau Command. She is a senior social worker and administrator of non-government organization. For many years, she intensively participated in and promoted the development of social welfare policy and planning, and services for elderly in Hong Kong. She had served in the following committees of the Hong Kong government: non-government organization representative to the Central Committee on Elderly Services, member of the Elderly Services Sub-committee in the drafting of 1991 White Paper on Social Welfare, non-government organization representative in annual reviews of Five Year Social Welfare Development Plans, member of Special Committee of Housing Authority on Elderly Housing.
She participated extensively in social welfare sector. In the Hong Kong Council of Social Service, she had served as Chairman of Elderly Division, member of the Executive Committee, member / Chairman of Committee on Agency Finance and Administration, etc. Since 1980s she was involved in planning and leading various exchanges between Hong Kong social welfare sector, and Ministry of Civil Affairs and National Aging Working Committee of Chinese Government, including regular mutual visits, social welfare development conferences, and personnel training. She served as Honorary Secretary and member of the Executive Committee of the Hong Kong Association of Gerontology for 18 years. She was actively involved in interdisciplinary collaboration to continuously raise standards of elderly services. She serves on three committees of the Association’s Residential Aged Care Accreditation Scheme (RACAS): Advisory, Steering and Accreditation. For more than ten years she fully involves in RACAS’s development, implementation, review and updating of accreditation standards, quality enhancement, and development. RACAS gained the certification of International Society for Quality in Health Care (ISQua) in 2008, and was the only Certification Scheme for RCHEs accredited by the Hong Kong Accreditation Service in 2014.
RN, RM, RTN, PRD(HCE), MSc, PhD, FAAN
Professor Diana Lee is the Professor of Nursing at the Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong. She is also the Director ofY.K. Pao Foundation Centre for Nursing Excellence in Chronic Illness Care and theDeputy Director of CUHK Jockey Club Institute of Ageing. Professor Lee was the Former Chairman of the Nursing Council of Hong Kong and is a fellow of the American Academy of Nursing.
Professor Lee's research interests lie in the areas of elderly health care and chronic illness care. She has been honored with the 'Excellent Research Award' by the Food and Health Bureau in 2007. Her research efforts are focused on promoting health-related quality of life for older people and patients with chronic illness, as well as on evaluating new initiatives for improving elderly health care services. In particular, she has conducted various studies to promote the
quality of care in nursing homes. Recently, she is investigating end-of-life issues in nursing homes and in the community. She also led the territory-wide CADENZA training programme which was a HK$73.8 million funding programme to provide gerontological education and foster positive community attitudes towards aging.
Professor Lee is dedicated to community service and has served on many government boards and councils. In recognition of her contributions to the community, she was appointed Justice of the Peace by the HKSAR Government in 2016.
Mr. Hermes Li is the Founder and Chief Investment Officer of Aspex Management, a Hong Kong based family office and investment company focused on Pan-Asian equities investing with a bottom-up fundamental investment approach.
Prior to founding Aspex Management in 2018, Mr. Li was an Executive Managing Director and Head of Asia Equities for Oz Management, one of the largest alternative asset managers globally. In his role, Mr. Li managed the OZ Asia Master Fund and oversaw Asia equities and private investments across the firm.
Prior to joining Oz Management in 2011, Mr. Li worked at Goldman, Sachs & Co. in Hong Kong as an Executive Director in the FICC division managing a capital structure trading portfolio covering equities, convertible and high-yield investments.
Mr. Li is from Hong Kong and holds a B.Sc. in Economics from the London School of Economics and Political Science.
Professor Chung-Mau Lo is Hospital Chief Executive at The University of Hong Kong-Shenzhen Hospital, Chin Lan-Hong Professor and Chair of Hepatobiliary and Pancreatic Surgery as well as Director of Liver Transplantation Centre at Queen Mary Hospital. He is internationally renowned for his expertise in hepatobiliary surgery, liver cancer and liver transplantation. He has published over 460 original articles in refereed national and international journals, and authored 12 book chapters. His pioneering work in adult right lobe living donor liver transplantation has revolutionalized the practice of liver transplant world-wide and has put Hong Kong and China on the world map of liver transplant. As a result, he and his team were awarded China’s top national honor of First-class State Scientific and Technological Progress Award in 2005 and First-class Award in Research Achievements in 2013. He serves in the editorial board of top journals in the field of surgery and transplantation and was the President of the International Liver Transplantation Society and the International Society for Digestive Surgery. He has been elected as an Honorary Fellow of the American Surgical Association and the American College of Surgeons, and alsoan Honorary Member of the European Surgical Association. In recognition of his contribution to public services, Professor Lo has been appointed as Justice of Peace by the Government of Hong Kong SAR since 2012, and awarded the Bronze Bauhinia Star in 2016.
He was conferred honorary professorships by several universities in China including Honorary Professorship for Infection Control by the Postgraduate Military Medical College of the PLA General Hospital (301). The People’s Liberation Army of China has in addition appointed him honorary consultant for Infection control in 1999.
He is also the past Chairman of the Scientific Committee on Infection Control of the Centre for Health Protection of HKSAR Government. He has authored over a hundred and fifty research papers including the book “Infection Control for the Asian Healthcare Worker”. Many international societies had invited him to speak on Infection Control.
The WHO has also regularly assigned him as advisor for various projects in Infection Control, Antibiotics Resistance and a core group member for the WHO Hand Hygiene guideline. He is also a member of the Emergency Committee of the International Health Regulations (IHR) of the WHO, member of the Global Infection Prevention and Control Network (GIPC) and Director of WHO Collaborating Centre for Infectious Disease Epidemiology and Control, The University of Hong Kong. He is also awarded the “Bronze Bauhinia Star” in 2004 and “Silver Bauhinia Star” in 2011 from the Hong Kong Government for his work in Infection Control in Hong Kong.
He is also active in the related field of Quality Healthcare Management and is presently the President of the Asia Pacific Society of Healthcare Quality. He is a Certified Professional in Healthcare Quality (CPHQ) and was the CPHQ Examination Committee in 2000-2001. He is also a F1000 Prime Faculty Member since 2014.
Professor Tang led the way with her research related to women’s health in Hong Kong, including the study of psychosexual issues in women and longitudinal study of menopausal symptoms, bone mineral density and bone loss in Chinese women, Chinese Medicine in the treatment of menopausal women, and the Human Papillomavirus (HPV) vaccine in the prevention of precancerous lesions of the cervix and the vulva.
She holds an MBBS (1971) and an MD (2006) from HKU, and has loyally remained at her alma mater for her entire professional career. As Dean of Medicine (1998-2001), Professor Tang successfully implemented a New Medical Curriculum, inspired by her passionate and memorable motto: “Failure is not an option.”
In 2011, she was seconded to the HKU-Shenzhen Hospital to serve as its Founding Hospital Chief Executive, to build a pilot hospital in Mainland China for healthcare reform, as well as a world-class hospital in clinical service, teaching and research.
Professor Tang has served as Chairman of the Board of the Li Ka Shing Faculty of Medicine, as founding Chairman of the Asian Medical Education Association, and has lent her leadership and service to many organisations in Hong Kong and abroad as well. She was elected President of the Hong Kong Academy of Medicine in 2005, and has made meaningful progress towards achieving Continuing Professional Development certification for medical professionals.
Professor Tang is a Fellow of the Hong Kong Academy of Medicine, and an Honorary Fellow of the Academy of Medicine of Singapore, the Royal College of Physicians (Ireland), the American College of Physicians, the Royal Australasian College of Physicians, the Hong Kong College of Obstetricians and Gynaecologists, and the Malaysian Academy of Medicine. She received the Young Scientist Award from the Asia-Oceania Federation of Obstetricians and Gynaecologists in 1991, and the Outstanding Women Professionals and Entrepreneurs Award in 2005.
Professor Tang was made a Justice of the Peace in 2001, and presented with a Silver Bauhinia Star in 2009.
Mrs. Carrie Willis is a well-respected public administrator with a wealth of experience in education, youth services and manpower development, having served in various Government bureaus and departments, as well as public bodies in Hong Kong. She was the Executive Director of the Vocational Training Council (VTC) before her retirement in 2013.
Mrs Willis has served on numerous boards and committees in the public, commerce and industrial sectors. Currently she is the Chairman of the Committee on Professional Development of Teachers and Principals; member of the Education Commission, the Standing Committee on Language Education and Research and various committees of the Vocational Training Council She is also a Governor on the board of the Canadian International School. She is a Justice of the Peace and was awarded SBS in 2009 and MBE in 1996.
Professor Jean Woo obtained her medical degree From Cambridge University in 1974, and joined the Medical Faculty of the Chinese University of Hong Kong in 1985, being responsible for undergraduate and postgraduate training in Geriatric Medicine. She is also Honorary Consultant of the Hospital Authority, being responsible for the development of acute, non-acute and community geriatric services in the NT East region between 1993 and 2010.
She is currently Emeritus Professor of Medicine, Henry G Leong Research Professor of Gerontology and Geriatrics, Director of the Jockey Club Institute of Aging at CUHK, the SH Ho Centre for Gerontology and Geriatrics, and the Centre for Nutritional Studies. She is actively engaged in pioneering novel models of community care of older people with the aid of technology, improving the quality of care at the end of life, strategies for healthy ageing, and healthcare training through empowerment.
Further details are available at:
MBBS(HK), MD(HK), FRCS(Glas), FRCPath(UK), FRCP(Edin & Lond)
Henry Fok Professor in Infectious Diseases
Chair of Infectious Diseases, Department of Microbiology
Co-Director, State Key Laboratory of Emerging Infectious Diseases
Academician, Chinese Academy of Engineering
Professor Yuen is the Director of State Key Laboratory of Emerging Infectious Diseases at the University of Hong Kong (HKU) and the Service Director (Pathology) of Hong Kong West Cluster. He has discovered over 70 novel viruses, bacteria, fungi or parasitic species, many of which are named after HKU or Hong Kong. He played a key role in the discovery of the agent causing SARS, the SARS coronavirus and the animal reservoir, thus leading to measures that were crucial to containing the SARS outbreak. The HKSAR government has honoured his contributions with the award of a Silver Bauhinia Star in 2004. He was elected to the Chinese Academy of Engineering (Basic Medicine) in 2007.
He is one of the world’s most highly cited researchers in the field of microbiology, as ranked by the Essential Science Indicator (ISI web), and has published more than 850 papers in international peer reviewed journals, with over 28,000 citations. His field of interest is novel microbes in emerging infectious disease outbreaks.